In the process of fighting the epidemic, Chinese medicine played an important role and became a bright spot to deal with the epidemic. From the novel coronavirus pneumonia diagnosis and treatment plan (trial version fourth), Chinese patent medicines such as flower scars and Herba Xiang Qi are recommended for many times, which provides a method and strategy for clinical treatment. Novel coronavirus pneumonia in TCM treatment of what advantages? What role did Chinese patent medicines such as Lianhua Qingwen and Huoxiang Zhengqi play in fighting the epidemic? Recently, Lian Fengmei, doctoral supervisor of Guang'anmen Hospital, Chinese Academy of traditional Chinese medicine, visited the "health lecture hall" of Xinhuanet and shared the above topics.
Lian Fengmei, doctoral supervisor of Guang'anmen Hospital, Chinese Academy of traditional Chinese medicine, visited xinhua.com
Novel coronavirus pneumonia is a "cold damp epidemic". Prevention and control of disease in autumn and winter need to be strengthened.
Xinhua: at present, China has made phased achievements in fighting against the epidemic, but the global epidemic is still severe. Many experts judge that the epidemic situation may rebound in autumn and winter. From the perspective of traditional Chinese medicine, what is the basis for this judgment?
Lian Fengmei: novel coronavirus pneumonia is a disease of TCM. It is called external pathogen. It is called pathogen. For epidemic diseases, it emphasizes its evil spirit. In the early stage of outbreak, Xiaolin academician led the team to the front line. Through investigation, it was considered that the new crown pneumonia is "cold damp epidemic", and "cold damp epidemic" has two characteristics, one is cold, the other two is wet. Novel coronavirus pneumonia is a cold season because of the cold and wet season. So, I think that autumn and winter may rebound, so we must pay attention to it and not let down lightly.
Xinhuanet.com: China novel coronavirus pneumonia is a highlight of China's program. What advantages do you have in treating new crown pneumonia with Chinese medicine and integrated traditional Chinese and Western medicine?
Even China: novel coronavirus pneumonia novel coronavirus pneumonia outbreak in early 2020, has a great impact on China and the world. In the process of fighting the epidemic, Chinese medicine and integrated traditional Chinese and Western medicine have played an important role in the epidemic. In the early stage of the outbreak, Chinese medicine was fully involved and deeply involved. Our team collected all novel coronavirus pneumonia data and collected the data collected from the front to find out the method, curative effect and characteristics of TCM treatment of new crown pneumonia. In fact, the effect of traditional Chinese medicine is reflected in all aspects of the treatment process, but where is the specific embodiment? For example, in a community in Wuchang District of Wuhan City, we distributed tens of thousands of traditional Chinese medicine formula granules to suspected or diagnosed mild patients, "cold dampness epidemic prescription" is also called Wuhan "No.1 prescription". Through data collection, it is found that the weight conversion rate of mild patients who have taken Wuhan "No.1 prescription" is very low, while there is a certain proportion of patients who do not take traditional Chinese medicine, and the difference is obvious.
For novel coronavirus pneumonia patients novel coronavirus pneumonia, novel coronavirus pneumonia patients with severe and critical illness were analyzed. All the new crown pneumonia patients with severe and severe diseases treated in Wuhan Hospital of integrated traditional Chinese and Western medicine were analyzed.
Novel coronavirus pneumonia novel coronavirus pneumonia patients have been discharged from hospital. The cause of "restoring Yang" has not been studied clearly. However, we still do not want to have "relapse". Therefore, the Chinese medicine patients who have cured and discharged from the new crown pneumonia are able to consolidate their condition and find that the rate of relapse is low. Novel coronavirus pneumonia can play a significant role in treating all stages of new crown pneumonia.
Syndrome differentiation and treatment highlights the advantages of traditional Chinese medicine in anti epidemic
Xinhuanet: you recently published a paper entitled "Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in the treatment of covid-19: randomized controlled trial". Would you like to talk about the research background and conclusion?
Lian Fengmei: our paper was published in the Journal of pharmacological research in the United States. The impact factor of this journal is 5.893. The novel coronavirus pneumonia and Lianhua Qingwen, which are mentioned in this paper, are proprietary Chinese medicines in the guideline of the diagnosis and treatment of new crown pneumonia. The guidelines are experts' consensus, but are there no evidence-based support? Given this consideration, our research theory is discussed from the perspective of "cold dampness epidemic". Huoxiang Zhengqi is a medicine for eliminating dampness, and Lianhua Qingwen is used for fever, cold and cold, wind heat and cold, etc. these two drugs are very common both in clinic and in people's cognition. Therefore, based on the theory of cold dampness disease and the characteristics of the two drugs, we designed this research project 。
The study was divided into three groups. The first group was not to use Huoxiang Zhengqi and Lianhua Qingwen; the second group was to add Lianhua Qingwen on the basis of basic medicine; the third group was to add Lianhua Qingwen and Huoxiang Zhengqi on the basis of basic medication. Huoxiang Zhengqi is the key point of eliminating dampness, which is the research background.
Novel coronavirus pneumonia is the first step to study the first two cases. The first is to see whether the Chinese patent medicines mentioned in the guidelines are effective. Second, we should see whether the theory of "new cold" is the right theory. There are 292 cases in this study, and they are grouped according to the above three situations. The results of the three groups show that the improvement of the symptoms of patients with traditional Chinese medicine is very obvious, and the use rate of antibiotics is reduced. Without the addition of Chinese patent medicine, the weight conversion rate is 11.1%. With the addition of Chinese patent medicine, we find that the weight conversion rate of the second group with Lianhua Qingwen is 8.6%, on this basis, Huoxiang Zhengqi is added The weight conversion rate was further reduced to 1.6%.
The novel coronavirus pneumonia has certain advantages in the condition of blocking the disease.
